Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 58 results.
User Information
Export Records
  1. 1.   Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Kotelkin, A. T.; Oreshkova, S. F.; Ilyichev, A. A.
  3. Molecular Biology. 2011, Feb; 45(1): 93-109.
  1. 2.   Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication
  2. Oguariri, R. M.; Adelsberger, J. W.; Baseler, M. W.; Imamichi, T.
  3. Virus Research. 2010, Nov; 153(2): 269-276.
  1. 3.   Structural basis of HIV-1 resistance to AZT by excision
  2. Tu, X. Y.; Das, K.; Han, Q. W.; Bauman, J. D.; Clark, A. D.; Hou, X. R.; Frenkel, Y. V.; Gaffney, B. L.; Jones, R. A.; Boyer, P. L.; Hughes, S. H.; Sarafianos, S. G.; Arnold, E.
  3. Nature Structural & Molecular Biology. 2010, Oct; 17(10): 1202-+.
  1. 4.   Loss of Rad51c Leads to Embryonic Lethality and Modulation of Trp53-Dependent Tumorigenesis in Mice
  2. Kuznetsov, S. G.; Haines, D. C.; Martin, B. K.; Sharan, S. K.
  3. Cancer Research. 2009 69(3): 863-872.
  1. 5.   Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect
  2. Gao, L.; Hanson, M. N.; Balakrishnan, M.; Boyer, P. L.; Roques, B. P.; Hughes, S. H.; Kim, B.; Bambara, R. A.
  3. Journal of Biological Chemistry. 2008 283(14): 9196-9205.
  1. 6.   Human defensins: synthesis and structural properties
  2. Pazgier, M.; Li, X.; Lu, W.; Lubkowski, J.
  3. Current Pharmaceutical Design. 2007 13(30): 3096-3118.
  1. 7.   Expression and purification of recombinant human alpha-defensins in Escherichia coli
  2. Pazgier, M.; Lubkowski, J.
  3. Protein Expression and Purification. 2006, Sep; 49(1): 1-8.
  1. 8.   High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs
  2. Mbulaiteye, S. M.; Walters, M.; Engels, E. A.; Bakaki, P. M.; Ndugwa, C. M.; Owor, A. M.; Goedert, J. J.; Whitby, D.; Biggar, R. J.
  3. Journal of Infectious Diseases. 2006, FEB 1; 193(3): 422-426.
  1. 9.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 10.   Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
  2. Khan, T.; Hixon, J. A.; Stauffer, J. K.; Lincoln, E.; Back, T. C.; Brenner, J.; Lockett, S.; Nagashima, K.; Powell, D.; Wigginton, J. M.
  3. Journal of the National Cancer Institute. 2006, FEB 1; 98(3): 190-202.
  1. 11.   Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection
  2. Yu, Q.; Park, J. H.; Doan, L. L.; Erman, B.; Feigenbaum, L.; Singer, A.
  3. Journal of Experimental Medicine. 2006, JAN 23; 203(1): 165-175.
  1. 12.   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
  2. Fuss, I. J.; Becker, C.; Yang, Z. Q.; Groden, C.; Hornung, R. L.; Heller, F.; Neurath, M. F.; Strober, W.; Mannon, P. J.
  3. Inflammatory Bowel Diseases. 2006, JAN; 12(1): 9-15.
  1. 13.   Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners
  2. Nallamsetty, S.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, JAN; 45(1): 175-182.
  1. 14.   Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus of obesity induced diabetes mouse: Implications on enteric neurodegeneration
  2. Surendran, S.; Kondapaka, S. B.
  3. Biochemical and Biophysical Research Communications. 2005, DEC 16; 338(2): 919-922.
  1. 15.   High level of functional polymorphism indicates a unique role of natural selection at human immune system loci
  2. Hughes, A. L.; Packer, B.; Welch, R.; Chanock, S. J.; Yeager, M.
  3. Immunogenetics. 2005, DEC; 57(11): 821-827.
  1. 16.   Persistent amyloidosis following suppression of A beta production in a transgenic model of Alzheimer disease
  2. Jankowsky, J. L.; Slunt, H. H.; Gonzales, V.; Savonenko, A. V.; Wen, J. C.; Jenkins, N. A.; Copeland, N. G.; Younkin, L. H.; Lester, H. A.; Younkin, S. G.; Borchelt, D. R.
  3. Plos Medicine. 2005, DEC; 2(12): 1318-1333.
  1. 17.   Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection
  2. Sun, L. L.; Finnegan, C. M.; Kish-Catalone, T.; Blumenthal, R.; Garzino-Demo, P.; Maggiore, G. M. L.; Berrone, S.; Kleinman, C.; Wu, Z. B.; Abdelwahab, S.; Lu, W. Y.; Garzino-Demo, A.
  3. Journal of Virology. 2005, NOV; 79(22): 14318-14329.
  1. 18.   Expression of hypoxia-inducible carbonic anhydrases in brain tumors
  2. Proescholdt, M. A.; Mayer, C.; Kubitza, M.; Schubert, T.; Liao, S. Y.; Stanbridge, E. J.; Ivanov, S.; Oldfield, E. H.; Brawanski, A.; Merrill, M. J.
  3. Neuro-Oncology. 2005, OCT; 7(4): 465-475.
  1. 19.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
  1. 20.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 21.   Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype
  2. Kowara, R.; Karaczyn, A.; Cheng, R. Y. S.; Salnikow, K.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2005, MAY 15; 205(1): 1-10.
  1. 22.   Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer
  2. Palmieri, D.; Halverson, D. O.; Ouatas, T.; Horak, C. E.; Salerno, M.; Johnson, J.; Figg, W. D.; Hollingshead, M.; Hursting, S.; Berrigan, D.; Steinberg, S. M.; Merino, M. J.; Steeg, P. S.
  3. Journal of the National Cancer Institute. 2005, MAY 4; 97(9): 632-642.
  1. 23.   p53 is a suppressor of inflammatory response in mice
  2. Komarova, E. A.; Krivokrysenko, V.; Wang, K. H.; Neznanov, N.; Chernov, M. V.; Komarov, P. G.; Brennan, M. L.; Golovkina, T. V.; Rokhlin, O.; Kuprash, D. V.; Nedospasov, S. A.; Hazen, S. R.; Feinstein, E.; Gudkov, A. V.
  3. Faseb Journal. 2005, APR; 19(6): Published online April 5, 2005.
  1. 24.   The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity
  2. Kaldis, P.
  3. Journal of Biological Chemistry. 2005, MAR 25; 280(12): 11165-11174.
  1. 25.   Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
  2. Mohamadzadeh, M.; Olson, S.; Kalina, W. V.; Ruthel, G.; Demmin, G. L.; Warfield, K. L.; Bavari, S.; Klaenhammer, T. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, FEB 22; 102(8): 2880-2885.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel